Market Overview

Genetics Technologies Executes Deal with InterWest Health of Missoula, Montana

Related GENE
BREVAGenplus(R) Offers a Solution to Physicians Concerned About the Revised Breast Cancer Screening Guidelines from the American Cancer Society (ACS)
Genetic Technologies Granted Key Patents by US Patent Office for BREVAGenplus

Genetic Technologies Limited (NASDAQ: GENE) is pleased to announce that, through its wholly-owned subsidiary Phenogen Sciences Inc., it has executed an agreement with InterWest Health of Missoula, Montana, USA, to use the InterWest provider network. InterWest Health is a regional provider network servicing seven north-western US states, including Montana, Idaho and Washington, that includes more than 15,000 health care providers. The agreement with InterWest Health is the eighth such credentialing agreement executed between the Company and similar US Preferred Provider Organisations (“PPOs”). The cumulative total number of covered lives for which its BREVAGen™ risk assessment test could be adjudicated as “in-network” now exceeds 102 million.

Posted-In: News Contracts


Related Articles (GENE)

Get Benzinga's Newsletters